Cargando…
Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice
BACKGROUND: Ginkgo biloba extract 50 (GBE50) has a variety of pharmacological functions such as anti-inflammatory, antioxidant and maintenance of glucose and lipid metabolism homeostasis. However, the therapeutic effects and mechanisms of GBE50 on non-alcoholic fatty liver disease (NAFLD) remain unk...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139725/ https://www.ncbi.nlm.nih.gov/pubmed/34040411 http://dx.doi.org/10.2147/JIR.S302934 |
_version_ | 1783696058583351296 |
---|---|
author | Li, Liu Yang, Li Yang, Feng Zhao, Xin-lan Xue, Shengjiang Gong, Fang-hua |
author_facet | Li, Liu Yang, Li Yang, Feng Zhao, Xin-lan Xue, Shengjiang Gong, Fang-hua |
author_sort | Li, Liu |
collection | PubMed |
description | BACKGROUND: Ginkgo biloba extract 50 (GBE50) has a variety of pharmacological functions such as anti-inflammatory, antioxidant and maintenance of glucose and lipid metabolism homeostasis. However, the therapeutic effects and mechanisms of GBE50 on non-alcoholic fatty liver disease (NAFLD) remain unknown. Therefore, in this study, we evaluated the therapeutic effects of GBE50 in NAFLD by using a high-fat diet (HFD) mice model. METHODS: C57BL/6J mice were fed a HFD diet for 15 weeks and were given respectively 25, 50, and 100 mg/kg GBE50 daily by gavage from 3 to 15 weeks. After the administration, blood samples and liver tissues were collected for biochemical detection, histological measurement, immunohistochemistry and Western blot, respectively. RESULTS: We found that GBE50 treatment could ameliorate insulin resistance (IR), glucose intolerance, lipid accumulation, hepatic steatosis and liver injury in HFD-fed mice. Further mechanism exploration discovered that the hepatoprotective effects of GBE50 on NAFLD may be related to the strengthening of IRS-1 signal activation and the weakening of NF-κB, Akt and endoplasmic reticulum stress signals activation. CONCLUSION: GBE50 is a potentially powerful therapeutic agent for the treatment of NAFLD. |
format | Online Article Text |
id | pubmed-8139725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-81397252021-05-25 Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice Li, Liu Yang, Li Yang, Feng Zhao, Xin-lan Xue, Shengjiang Gong, Fang-hua J Inflamm Res Original Research BACKGROUND: Ginkgo biloba extract 50 (GBE50) has a variety of pharmacological functions such as anti-inflammatory, antioxidant and maintenance of glucose and lipid metabolism homeostasis. However, the therapeutic effects and mechanisms of GBE50 on non-alcoholic fatty liver disease (NAFLD) remain unknown. Therefore, in this study, we evaluated the therapeutic effects of GBE50 in NAFLD by using a high-fat diet (HFD) mice model. METHODS: C57BL/6J mice were fed a HFD diet for 15 weeks and were given respectively 25, 50, and 100 mg/kg GBE50 daily by gavage from 3 to 15 weeks. After the administration, blood samples and liver tissues were collected for biochemical detection, histological measurement, immunohistochemistry and Western blot, respectively. RESULTS: We found that GBE50 treatment could ameliorate insulin resistance (IR), glucose intolerance, lipid accumulation, hepatic steatosis and liver injury in HFD-fed mice. Further mechanism exploration discovered that the hepatoprotective effects of GBE50 on NAFLD may be related to the strengthening of IRS-1 signal activation and the weakening of NF-κB, Akt and endoplasmic reticulum stress signals activation. CONCLUSION: GBE50 is a potentially powerful therapeutic agent for the treatment of NAFLD. Dove 2021-05-17 /pmc/articles/PMC8139725/ /pubmed/34040411 http://dx.doi.org/10.2147/JIR.S302934 Text en © 2021 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Li, Liu Yang, Li Yang, Feng Zhao, Xin-lan Xue, Shengjiang Gong, Fang-hua Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice |
title | Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice |
title_full | Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice |
title_fullStr | Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice |
title_full_unstemmed | Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice |
title_short | Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice |
title_sort | ginkgo biloba extract 50 (gbe50) ameliorates insulin resistance, hepatic steatosis and liver injury in high fat diet-fed mice |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139725/ https://www.ncbi.nlm.nih.gov/pubmed/34040411 http://dx.doi.org/10.2147/JIR.S302934 |
work_keys_str_mv | AT liliu ginkgobilobaextract50gbe50amelioratesinsulinresistancehepaticsteatosisandliverinjuryinhighfatdietfedmice AT yangli ginkgobilobaextract50gbe50amelioratesinsulinresistancehepaticsteatosisandliverinjuryinhighfatdietfedmice AT yangfeng ginkgobilobaextract50gbe50amelioratesinsulinresistancehepaticsteatosisandliverinjuryinhighfatdietfedmice AT zhaoxinlan ginkgobilobaextract50gbe50amelioratesinsulinresistancehepaticsteatosisandliverinjuryinhighfatdietfedmice AT xueshengjiang ginkgobilobaextract50gbe50amelioratesinsulinresistancehepaticsteatosisandliverinjuryinhighfatdietfedmice AT gongfanghua ginkgobilobaextract50gbe50amelioratesinsulinresistancehepaticsteatosisandliverinjuryinhighfatdietfedmice |